BELLEVILLE – The widow of a man who died from a brain hemorrhage is suing a pharmaceutical company, alleging problems with a drug he was taking prior to his death.
Lorraine Buesking of Belleville, individually and as special administrator of the estate of Forrest J. Buesking, filed the lawsuit Feb. 16 in St. Clair County Circuit Court against Boehringer Ingelheim Pharmaceutical Inc., alleging product liability
According to the complaint, Forrest Buesking had been prescribed and was using Pradaxa, manufactured by the defendant and distributed in St. Clair County.
On Feb. 16, 2014, the suit says, Buesking fell in his front yard and bumped his head. Unbeknownst to him or the Lorraine Buesking, the lawsuit states, he sustained a cerebral hemorrhage as a result of that fall. The plaintiff drove her husband to the hospital but he died from the internal bleeding, the suit states.
The complaint alleges Pradaxa was unreasonably dangerous in that the defendant had not developed a drug to counteract the Pradaxa to allow coagulation of a hemorrhage. The lawsuit further alleges Boehringer Ingelheim failed to warn the plaintiff that vitamin K would lead to coagulation.
As a result of the dangerous nature of Pradaxa, the complaint states, the plaintiff's husband died Feb. 16, 2014. He suffered significant pain before he died and the plaintiff has been deprived of his care, comfort, support and society ever since, the suit says.
Lorraine Buesking seeks more than $50,000, plus court costs. She is represented by attorney Michael L. McGlynn of McGlynn & McGlynn in Belleville.
St. Clair County Circuit Court case number 16-L-92